Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,886,571 papers from all fields of science
Search
Sign In
Create Free Account
CIL-2 102
Known as:
CIL-102
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Discovery of Novel N-alkyl 4-anilinofuro[2,3-b]quinoline Derivatives (CIL-102 Derivatives) Against Castration-resistant Human Prostate Cancers.
We-Fen Lo
,
Y. Chou
,
+6 authors
C. Tzeng
Anti-Cancer Agents in Medicinal Chemistry
2015
Corpus ID: 46687359
A number of N-alkylated 4-anilinofuro[2,3-b]quinoline derivatives were synthesized and evaluated in vitro against PC-3, A549, and…
Expand
2013
2013
Quantitative proteomic analysis of the inhibitory effects of CIL-102 on viability and invasiveness in human glioma cells.
Chih‐Chuan Teng
,
H. Kuo
,
C. Sze
Toxicology and Applied Pharmacology
2013
Corpus ID: 29411518
2012
2012
CIL-102 binds to tubulin at colchicine binding site and triggers apoptosis in MCF-7 cells by inducing monopolar and multinucleated cells.
K. K. Gireesh
,
A. Rashid
,
Soumyananda Chakraborti
,
D. Panda
,
T. Manna
Biochemical Pharmacology
2012
Corpus ID: 21356042
2012
2012
The inhibitory effect of CIL-102 on the growth of human astrocytoma cells is mediated by the generation of reactive oxygen species and induction of ERK1/2 MAPK.
Chih‐Chuan Teng
,
H. Kuo
,
Hongwei Cheng
,
Ting-Chung Wang
,
C. Sze
Toxicology and Applied Pharmacology
2012
Corpus ID: 5600950
2012
2012
CIL-102 induces matrix metalloproteinase-2 (MMP-2)/MMP-9 down-regulation via simultaneous suppression of genetic transcription and mRNA stability.
Wen‐Hsin Liu
,
Yeh Chen
,
Long-Sen Chang
International Journal of Biochemistry and Cell…
2012
Corpus ID: 25437460
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required